Literature DB >> 26370630

Inhaled treprostinil via the Tyvaso Inhalation System through a tracheostomy.

Jeryl Huckaby1, Patricia Lawrence1, Andrea Center1, Dawn Simon2.   

Abstract

A 20-year-old man with pulmonary arterial hypertension secondary to systemic sclerosis was admitted to our hospital. Prior to admission, his PAH had been successfully managed with the use of tadalafil, ambrisentan and inhaled Tyvaso. Owing to respiratory failure from vocal cord paralysis, he underwent an emergent tracheotomy. The delivery of inhaled Tyvaso through a tracheostomy tube was explored. Post-tracheostomy, the patient continued his ability to self-administer the medication. His WHO functional classification, brain natriuretic peptide levels, and echocardiograms were not significantly different when Tyvaso was administered via tracheostomy compared with oral administration. This case report summarises the method used to deliver Tyvaso via a tracheostomy tube, which proved to be successful in this patient. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26370630      PMCID: PMC4577659          DOI: 10.1136/bcr-2015-211602

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

1.  Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.

Authors:  Vallerie V McLaughlin; Raymond L Benza; Lewis J Rubin; Richard N Channick; Robert Voswinckel; Victor F Tapson; Ivan M Robbins; Horst Olschewski; Melvyn Rubenfire; Werner Seeger
Journal:  J Am Coll Cardiol       Date:  2010-05-04       Impact factor: 24.094

2.  Effectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in children.

Authors:  Usha Krishnan; Shinichi Takatsuki; Dunbar D Ivy; Jason Kerstein; Michelle Calderbank; Elizabeth Coleman; Erika B Rosenzweig
Journal:  Am J Cardiol       Date:  2012-08-21       Impact factor: 2.778

3.  Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension.

Authors:  Shinichi Takatsuki; Donna K Parker; Aimee K Doran; Robert H Friesen; D Dunbar Ivy
Journal:  Pediatr Cardiol       Date:  2012-11-27       Impact factor: 1.655

Review 4.  Inhaled treprostinil: a therapeutic review.

Authors:  Richard N Channick; Robert Voswinckel; Lewis J Rubin
Journal:  Drug Des Devel Ther       Date:  2012-01-24       Impact factor: 4.162

  4 in total
  1 in total

1.  Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling.

Authors:  Jahidur Rashid; Eva Nozik-Grayck; Ivan F McMurtry; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-11       Impact factor: 5.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.